Dear O 'Dear , the second approved test in the UK Global Access Diagnostics is Roche's Covid-19 test that was booted from Germany , they got in under Emergency use authorisation by FDA then into the UK , won't be long till Roche's will be booted from UK also with that poor sensitivity, Anteotec's RAT test looks the best test fit for purpose , compare to Roche that spent $12 billion on R&D , Anteotech has done very well indeed .
The Roche Group, headquartered in Basel, Switzerland, is active in over 100 countries and in 2020 employed more than 100,000 people worldwide. In 2020, Roche invested CHF 12.2 billion in R&D and posted sales of CHF 58.3 billion. Genentech, in the United States, is a wholly owned member of the Roche Group. Roche is the majority shareholder in Chugai Pharmaceutical, Japan. For more information, please visit www.roche.com.
Roche, Abbott COVID Antigen Tests Just So-So in Real-World Data
— "Unsatisfactory" for screening asymptomatic people, say German lab professionals
by John Gever, Contributing Writer, MedPage Today August 9, 2021
Sensitivities for the antigen tests were especially low -- under 40% -- when the individuals had no comorbidities, were asymptomatic (just 23% for the Abbott test and barely 30% for Roche's), or had previously recovered from COVID.
Among 2,215 "all-comers" tested at a German diagnostics lab, with 338 ultimately showing positive results with PCR testing, Roche's SD Biosensor and Abbott's Panbio rapid antigen tests showed overall sensitivities of 60.4% and 56.8%, respectively, reported Christoph Wertenauer, of Synlab GmbH in Augsburg and the University of Heidelberg in Mannheim, and colleagues.
https://www.medpagetoday.com/infectiousdisease/covid19/93961
March 2020
Roche SARS-CoV-2 molecular test granted first FDA Emergency Use Authorization for PCR testing of both symptomatic and asymptomatic individuals at the point of care
https://diagnostics.roche.com/globa...symptomatic-and-asymptomatic-individuals.html
- Forums
- ASX - By Stock
- ADO
- EuGeni
EuGeni, page-1765
-
-
- There are more pages in this discussion • 901 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ADO (ASX) to my watchlist
|
|||||
Last
2.1¢ |
Change
0.000(0.00%) |
Mkt cap ! $51.83M |
Open | High | Low | Value | Volume |
2.1¢ | 2.2¢ | 2.1¢ | $3.414K | 161.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 384663 | 2.1¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.2¢ | 616353 | 6 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 384663 | 0.021 |
12 | 2157550 | 0.020 |
10 | 3040767 | 0.019 |
10 | 1652665 | 0.018 |
4 | 194160 | 0.017 |
Price($) | Vol. | No. |
---|---|---|
0.022 | 616353 | 6 |
0.023 | 857853 | 5 |
0.024 | 1306228 | 3 |
0.025 | 254144 | 5 |
0.027 | 680612 | 2 |
Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
Featured News
RNU
Renascor wins a funding boost given it wants to produce a critical mineral – but $5M award pales in comparison to some
SKS
SKS Technologies wins US$90M award to supply power to international hyperscale data centre in Melbourne
ADO (ASX) Chart |